BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3383110)

  • 1. Image cytometric classification of premalignant breast disease in fine needle aspirates.
    King EB; Chew KL; Duarte L; Hom JD; Mayall BH; Miller TR; Petrakis NL
    Cancer; 1988 Jul; 62(1):114-24. PubMed ID: 3383110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
    King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
    Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
    Mridha AR; Iyer VK; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer: early diagnosis of precursor lesions and clinically inapparent carcinoma by fine needle aspiration.
    Linsk JA
    Med Oncol Tumor Pharmacother; 1991; 8(3):169-74. PubMed ID: 1803177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
    Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
    Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
    Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
    Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premalignant conditions and markers of elevated risk in the breast and their management.
    Page DL; Dupont WD
    Surg Clin North Am; 1990 Aug; 70(4):831-51. PubMed ID: 2371647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic risk factors for breast cancer in women with benign breast disease.
    Page DL; Dupont WD
    Semin Surg Oncol; 1988; 4(4):213-7. PubMed ID: 2854655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.
    Moore MM; Hargett CW; Hanks JB; Fajardo LL; Harvey JA; Frierson HF; Slingluff CL
    Ann Surg; 1997 Jun; 225(6):726-31; discussion 731-3. PubMed ID: 9230813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria and cancer risk of proliferative breast lesions.
    Jensen RA; Dupont WD; Page DL
    J Cell Biochem Suppl; 1993; 17G():59-64. PubMed ID: 8007711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric analysis of fine needle aspirates from breast lesions.
    Mapstone NP; Zakhour HD
    Cytopathology; 1990; 1(6):349-55. PubMed ID: 2101681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radial scar/complex sclerosing lesions: a clinicopathologic correlation study from a single institution.
    Nassar A; Conners AL; Celik B; Jenkins SM; Smith CY; Hieken TJ
    Ann Diagn Pathol; 2015 Feb; 19(1):24-8. PubMed ID: 25578683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
    Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
    Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.